Home > Insider Trading > Filing (0001415889-24-000880)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	Pharmaceutical Preparations (2834)	831281555

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1974200	Jolanda Howe	C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404	Svp, Global Controller	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-06	1,250	$0.00	1,250	No	4	M	Direct
Common Stock	Disposition	2024-01-08	528	$28.04	722	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2024-01-06	1,250	$0.00	1,250	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,250			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025.